PIK3CA and Cognitive impairment: While the PI3K signaling pathway has been implicated in age-associated cognitive impairment [39], BYL719 does not cross the blood brain barrier, and thus, it is not surprising that in middle-aged mice BYL719 treatment did not affect mouse exploratory activity.